Accueil / Tag Archives: Other Health

Tag Archives: Other Health

Afya Educacional (NASDAQ:AFYA) Lists on NASDAQ

Friday, July 19th 2019 at 7:25pm UTC Brazil’s largest medical education group seeks to transform medical education NEW YORK–(BUSINESS WIRE)– Today, Afya Educacional (“Afya” or “the Company”), Brazil’s largest medical education group,1 lists on the Nasdaq under the ticker symbol NASDAQ:AFYA. The initial public offering of 13,744,210 Class A common …

Plus »

Top 5 Vendors in the Mercury Analyzer Market from 2019 to 2023 | Technavio

Friday, July 19th 2019 at 1:39pm UTC LONDON–(BUSINESS WIRE)– Several government bodies across the world are enforcing stringent regulations to tackle the adverse environmental effects of mercury emission. Mercury analyzers help in measuring furnace temperature and the flue gas of air pollutants. Thus, the enforcement of strict regulations to monitor …

Plus »

Transgene Receives MHRA Approval for a Clinical Trial of TG6002, a Next-generation Oncolytic Virus, Administered by Intrahepatic Artery Infusion in Patients with Colorectal Cancer with Liver Metastases

Thursday, July 18th 2019 at 3:45pm UTC TG6002 has multiple mechanisms of action for enhanced anti-tumor activity: oncolysis, local production of chemotherapy in tumor and cell-mediated immune response The Phase 1/2a trial is expected to start in Q4 2019 STRASBOURG, France–(BUSINESS WIRE)– Regulatory News: Transgene (Paris:TNG), a biotech company that …

Plus »

Transgene Receives MHRA Approval for a Clinical Trial of TG6002, a Next-generation Oncolytic Virus, Administered by Intrahepatic Artery Infusion in Patients with Colorectal Cancer with Liver Metastases

Thursday, July 18th 2019 at 3:45pm UTC TG6002 has multiple mechanisms of action for enhanced anti-tumor activity: oncolysis, local production of chemotherapy in tumor and cell-mediated immune response The Phase 1/2a trial is expected to start in Q4 2019 STRASBOURG, France–(BUSINESS WIRE)– Regulatory News: Transgene (Paris:TNG), a biotech company that …

Plus »

CTD Holdings Scientific Advisory Board Endorses Alzheimer’s Disease as Next Indication for Company’s Trappsol® Cyclo™ Drug Development Program

Thursday, July 18th 2019 at 2:24pm UTC ALACHUA, Fla.–(BUSINESS WIRE)– CTD Holdings, Inc. (OTCQB: CTDH), a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, today announced that the Company’s Scientific Advisory Board endorsed Alzheimer’s Disease as the company’s next drug development indication. …

Plus »

CTD Holdings Scientific Advisory Board Endorses Alzheimer’s Disease as Next Indication for Company’s Trappsol® Cyclo™ Drug Development Program

Thursday, July 18th 2019 at 2:24pm UTC ALACHUA, Fla.–(BUSINESS WIRE)– CTD Holdings, Inc. (OTCQB: CTDH), a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, today announced that the Company’s Scientific Advisory Board endorsed Alzheimer’s Disease as the company’s next drug development indication. …

Plus »

Ending Financial Help for Specialty Drug Co-pays Cuts Patient Use of Medications, AJMC® Study Finds

Wednesday, July 17th 2019 at 4:20pm UTC Capping patient assistance for specialty prescription drugs may lead to lower medication adherence, according to findings published in The American Journal of Managed Care® (AJMC®). In an accompanying editorial, AJMC®’s co-editor-in-chief calls for a “truce” between drug makers and payers so that cost …

Plus »

AtriCure to Participate at the Canaccord Genuity 39th Annual Growth Conference

Wednesday, July 17th 2019 at 8:00pm UTC MASON, Ohio–(BUSINESS WIRE)– AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced that the company will be participating in the upcoming Canaccord Genuity 39th Annual Growth Conference in Boston. AtriCure’s management …

Plus »

OncoCell MDx Appoints Renowned Urologic Pathologist as Chief Medical Officer

Thursday, July 18th 2019 at 12:45pm UTC ROYAL OAK, Mich.–(BUSINESS WIRE)– OncoCell MDx, an immunogenomics platform company specializing in the delivery of novel, noninvasive molecular diagnostic assays, today announced that Kirk Wojno, M.D., has joined the company’s leadership team as its Chief Medical Officer. Dr. Wojno, a renowned urologic pathologist …

Plus »

Medicare Releases Final Local Coverage Determination Providing Coverage of Optune® for Newly Diagnosed Glioblastoma

Thursday, July 18th 2019 at 10:57am UTC ST. HELIER, Jersey–(BUSINESS WIRE)– Novocure (NASDAQ: NVCR) today announced the Medicare durable medical equipment (DME) Medicare Administrative Contractors (MACs) have released a final local coverage determination (LCD) providing coverage of Optune for Medicare beneficiaries with newly diagnosed glioblastoma (GBM) effective September 1, 2019. …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.